Richard C. Kevin

Pharmacology of Valinate and<i>tert</i>-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues

Samuel D. Banister, Mitchell Longworth, Richard C. Kevin et al. · ACS Chemical Neuroscience · 2016 · 246 citations

Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA

Samuel D. Banister, Michael Moir, Jordyn Stuart et al. · ACS Chemical Neuroscience · 2015 · 239 citations

Cannabis Use, Medicinal Chemistry, Drug Target +14

Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135

Samuel D. Banister, Jordyn Stuart, Richard C. Kevin et al. · ACS Chemical Neuroscience · 2015 · 194 citations

Drug Target, Pharmacotherapy, Experimental Pharmacology +20

Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition

Thomas R. Arkell, Nicholas Lintzeris, Richard C. Kevin et al. · Psychopharmacology · 2019 · 172 citations · Full text

Effect of Cannabidiol and Δ⁹-Tetrahydrocannabinol on Driving Performance

Thomas R. Arkell, Frederick Vinckenbosch, Richard C. Kevin et al. · JAMA · 2020 · 166 citations · Full text